Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. | 80,015 | reported | 26 May 2026 | tx 53+1,045,605−1,455,331 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 May 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 60,000 | 10.00 USD | 10b5-1 |
| 26 May 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 5,000 | 10.90 USD | 10b5-1 |
| 26 May 2026 | SALE | NewAmsterdam Pharma Co N.V. | 65,000 | 35.69 USD | 10b5-1 |
| 26 May 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 60,000 | 0.00 USD | 10b5-1deriv |
| 26 May 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 5,000 | 0.00 USD | 10b5-1deriv |
| 28 Jan 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 32,612 | 10.90 USD | |
| 27 Jan 2026 | SALE | NewAmsterdam Pharma Co N.V. | 39,816 | 32.62 USD | |
| 27 Jan 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 39,816 | 10.90 USD | |
| 28 Jan 2026 | SALE | NewAmsterdam Pharma Co N.V. | 32,612 | 31.80 USD | |
| 28 Jan 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 32,612 | 0.00 USD | deriv |
| 27 Jan 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 39,816 | 0.00 USD | deriv |
| 23 Jan 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 38,172 | 10.90 USD | |
| 23 Jan 2026 | SALE | NewAmsterdam Pharma Co N.V. | 25,405 | 33.44 USD | |
| 23 Jan 2026 | SALE | NewAmsterdam Pharma Co N.V. | 12,767 | 34.37 USD | |
| 26 Jan 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 34,400 | 10.90 USD | |
| 26 Jan 2026 | SALE | NewAmsterdam Pharma Co N.V. | 34,091 | 32.77 USD | |
| 26 Jan 2026 | SALE | NewAmsterdam Pharma Co N.V. | 309 | 33.45 USD | anomaly |
| 26 Jan 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 34,400 | 0.00 USD | deriv |
| 23 Jan 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 38,172 | 0.00 USD | deriv |
| 07 Jan 2026 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 12,000 | — | |
| 05 Jan 2026 | SALE | NewAmsterdam Pharma Co N.V. | 2,647 | 33.25 USD | |
| 07 Jan 2026 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 53,500 | 0.00 USD | deriv |
| 26 Dec 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 38,872 | 10.00 USD | |
| 26 Dec 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 5,000 | 10.90 USD | |
| 26 Dec 2025 | SALE | NewAmsterdam Pharma Co N.V. | 43,872 | 35.30 USD |